These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7039878)

  • 1. Inhibition of the in vitro growth of Plasmodium falciparum by human polymorphonuclear neutrophil leucocytes.
    Brown J; Smalley ME
    Clin Exp Immunol; 1981 Oct; 46(1):106-9. PubMed ID: 7039878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes.
    Kharazmi A; Jepsen S
    Clin Exp Immunol; 1984 Aug; 57(2):287-92. PubMed ID: 6380830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizonts, merozoites, and phagocytosis in falciparum malaria.
    Sun T; Chakrabarti C
    Ann Clin Lab Sci; 1985; 15(6):465-9. PubMed ID: 3904592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis of Plasmodium falciparum-parasitized erythrocytes by human polymorphonuclear leukocytes.
    Celada A; Cruchaud A; Perrin LH
    J Parasitol; 1983 Feb; 69(1):49-53. PubMed ID: 6338199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malaria infection in patients with sickle cell anemia].
    Sroczyński J
    Pol Tyg Lek; 1977 Apr; 32(17):637-8. PubMed ID: 325541
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous in vitro cultivation of Plasmodium falciparum and its applications in immunology of malaria.
    Sivaraman CA
    J Commun Dis; 1985; 17(1 Suppl):23-30. PubMed ID: 3913697
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro.
    Muniz-Junqueira MI; dos Santos-Neto LL; Tosta CE
    Cell Immunol; 2001 Mar; 208(2):73-9. PubMed ID: 11333139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Save the children.
    Hoffman S
    Nature; 2004 Aug; 430(7002):940-1. PubMed ID: 15318239
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection.
    Perch M; Kofoed P; Fischer TK; Có F; Rombo L; Aaby P; Eugen-Olsen J
    Parasite Immunol; 2004 May; 26(5):207-11. PubMed ID: 15491469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria blood-stage infection and its control by the immune system.
    Perlmann P; Troye-Blomberg M
    Folia Biol (Praha); 2000; 46(6):210-8. PubMed ID: 11140853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a neutrophil-mediated protective response in malaria.
    Nnalue NA; Friedman MJ
    Parasite Immunol; 1988 Jan; 10(1):47-58. PubMed ID: 3281102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remarkable polymorphonuclear phagocytosis of P. falciparum.
    Laing AB; Wilson M
    Trans R Soc Trop Med Hyg; 1972; 66(4):523. PubMed ID: 4561001
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocyte alkaline phosphatase in Plasmodium falciparum malaria.
    Bregani ER; Tu VT; Pomati M; Figini G; Manenti F
    Haematologica; 2004 Apr; 89(4):494-5. PubMed ID: 15075085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
    Hermsen CC; Verhage DF; Telgt DS; Teelen K; Bousema JT; Roestenberg M; Bolad A; Berzins K; Corradin G; Leroy O; Theisen M; Sauerwein RW
    Vaccine; 2007 Apr; 25(15):2930-40. PubMed ID: 16914240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgE elevation and anti-plasmodium falciparum IgE antibodies: association of high level with malaria resistance.
    Khusmith S; Panitchakorn J; Krudsood S; Wilairatana P; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):696-701. PubMed ID: 12041541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
    Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum.
    Salmon D; Vilde JL; Andrieu B; Simonovic R; Lebras J
    Infect Immun; 1986 Mar; 51(3):801-6. PubMed ID: 3512435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated in vitro growth inhibition of field isolates of Plasmodium falciparum from asymptomatic children in Burkina Faso.
    Bolad A; Nebié I; Cuzin-Ouattara N; Traore A; Esposito F; Berzins K
    Am J Trop Med Hyg; 2003 Jun; 68(6):728-33. PubMed ID: 12887035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.
    Tjitra E; Suprianto S; McBroom J; Currie BJ; Anstey NM
    J Clin Microbiol; 2001 Mar; 39(3):1025-31. PubMed ID: 11230422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children.
    Luty AJ; Bongartz M; Rezbach P; Faucher JF; Hollingdale MR; Kremsner PG
    Eur Cytokine Netw; 2001; 12(4):647-53. PubMed ID: 11781192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.